Northwest Biotherapeutics (NWBO) Reports Survival Data from DCVax®-L Study Mar 27, 2015 09:08AM

Northwest Biotherapeutics, Inc. (NASDAQ: NWBO) ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for cancer, announced today that Dr. Marnix Bosch, the Company's Chief Technical Officer, presented encouraging survival data on 51 Glioblastoma multiforme (GBM) brain cancer patients treated with DCVax®-L. The data showed substantially longer than expected survival in patients with apparent early progression (recurrence) of their cancer,... (continue reading...)


RXI Pharma (RXII), MirImmune Enter into Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA Mar 27, 2015 09:04AM

RXi Pharmaceuticals Corporation (NASDAQ: RXII) and privately-held MirImmune LLC, today announced that they have entered into an exclusive license agreement to RXi's novel and proprietary sd-rxRNA® technology for use in developing innovative cell-based cancer immunotherapies. The collaboration has the potential to result in novel, more effective and patient friendly cancer treatments that could be a significant step toward personalized medicine.

Under the terms of the... (continue reading...)


RXI Pharma (RXII) Enters Exclusive License Deal with MirImmune for Self-Delivering RNAi (sd-rxRNA) Technology Mar 27, 2015 09:03AM

RXI Pharma (NASDAQ: RXII) and privately-held MirImmune LLC, today announced that they have entered into an exclusive license agreement to RXi's novel and proprietary sd-rxRNA® technology for use in developing innovative cell-based cancer immunotherapies. The collaboration has the potential to result in novel, more effective and patient friendly cancer treatments that could be a significant step toward personalized medicine.

Under the terms of the agreement, MirImmune... (continue reading...)


Hospira (HSP) Data to Be Presented at the National Kidney Foundation Meeting Mar 27, 2015 09:02AM

Hospira, Inc. (NYSE: HSP), a global leader in biosimilars and the world's leading provider of injectable drugs and infusion technologies, presented two studies that support an evaluation of biosimilarity of its proposed biosimilar, Epoetin Hospira, with the U.S. Food and Drug Administration (FDA) conditionally approved name of RETACRIT™, compared to the reference product, Amgen's EPOGEN™ (epoetin alfa). These study data were presented at the National Kidney... (continue reading...)


Microvision (MVIS) Receives $8M Up-Front License Fee Payment Mar 27, 2015 09:02AM

Microvision (NASDAQ: MVIS) announced it has received an $8 million license fee payment from its Fortune Global 100 partner.

The up-front license fee is part of a multi-year license agreement MicroVision announced earlier this month with its Fortune Global 100 partner for MicroVision PicoP® display technology. The license agreement grants the Fortune Global 100 company a non-exclusive license to MicroVision PicoP display technology for use in display modules it... (continue reading...)


More Corporate News

View Older Stories

Mar 27, 2015 08:46AM Orbital ATK (OA) Successfully Launches Scientific Balloon Flight
Mar 27, 2015 08:32AM Flamel Technologies (FLML) Announces Positive LiquiTime Guaifenesin Clinical Trial Results
Mar 27, 2015 08:03AM Hecla Mining (HL) to Acquire Revett (RVM) in $20M Stock Deal
Mar 27, 2015 07:31AM Kaman (KAMN) Announces $58M Contract Modification Award
Mar 27, 2015 07:11AM Ohr Pharmaceutical (OHRP) Reports Phase II IMPACT Missed Primary Endpoint in Classic CNV
Mar 27, 2015 07:08AM BlackBerry (BBRY), China Mobile HK (CHL) Enter Agreement for Enhanced SIM-Based Licensing by BlackBerry for Enterprise Customers
Mar 27, 2015 07:04AM Dow Chemical (DOW) to Separate Chlor-Alkali Unit, Merge it with Olin (OLN)
Mar 27, 2015 06:14AM Quicksilver (ZQK) Offers Restated FY14 Results
Mar 27, 2015 06:01AM Jiayuan.com (DATE) Taps Legal Counsel, Financial Advisor to Evaluate 'Going Private' Proposal
Mar 27, 2015 05:50AM Chevron (CVX) Unit Enters Agreement to Sell CAL Stake
Mar 26, 2015 05:49PM UPDATE: Ebola Test Vaccines Appear Safe in Phase 2 Liberian Trial (NWLK) (GSK) (MRK)
Mar 26, 2015 05:24PM Ocwen Financial (OCN) Begins Entering Indemnification Agreements with Directors, Execs
Mar 26, 2015 05:19PM Yahoo! (YHOO) Approves Additional $2B Buyback
Mar 26, 2015 04:27PM Carnival Corp. (CCL) Enters MUA to Add Nine Cruise Ships to Its Fleet Beginning in 2022
Mar 26, 2015 04:17PM Accenture (ACN) Announces Completion of Agilex Technologies Acquisition
Mar 26, 2015 04:09PM RBC Bearings (ROLL) to Buy Dover's (DOV) Sargent Aerospace & Defense Business in $500M Deal
Mar 26, 2015 03:56PM Rockwell Medical (RMTI) Triferic Data Selected for Four Poster Presentations at KNF
Mar 26, 2015 03:22PM Sutron (STRN) Says Prior Financial Statements Should Not be Relied Upon
Mar 26, 2015 02:24PM Orexigen Therapeutics' (OREX) Mysimba Approved in Europe
Mar 26, 2015 02:24PM Orexigen Therapeutics (OREX) Receives EC Approval for Mysimba
Mar 26, 2015 01:15PM Ovascience (OVAS) AUGMENT Results to Be Featured at Society for Reproductive Investigation Meeting
Mar 26, 2015 12:33PM Novo Nordisk (NVO) Will Submit Prespecified Interim Analysis of DEVOTE as Part of Resubmitted Tresiba, Ryzodeg NDA
Mar 26, 2015 11:57AM Telefonica Brasil (VIV) Launches 219.95M Preferred Offering
Mar 26, 2015 11:25AM Neustar (NSR) Issues Response to FCC Number Contract Determination
Mar 26, 2015 10:49AM Windstream (WIN) Gives Final Approval for REIT Spinoff, Declares Prorated Dividend, Affirms Guidance
Mar 26, 2015 10:30AM Twitter (TWTR) Debuts Live Video for Mobile with Periscope
Mar 26, 2015 09:47AM Amazon.com (AMZN) Announces Unlimited Cloud Drive Storage for Consumers
Mar 26, 2015 09:33AM On Track Innovations (OTIV) Confirms Patent Win Against T-Mobile
Mar 26, 2015 09:30AM Zogenix (ZGNX) Commences Relday Phase 1b Dosing (DRRX)
Mar 26, 2015 09:26AM Tekmira Pharma (TKMR) Presents Positive Preclincal Data on TKM-HTG as HTG Treatment
Mar 26, 2015 09:21AM Sucampo Pharma (SCMP) Prices 4M Common Secondary Offering at $14/Share
Mar 26, 2015 08:48AM Rosetta Genomics (ROSG) Awarded Patent for its Novel Kidney Cancer Test
Mar 26, 2015 08:40AM Schlumberger (SLB) Unit, U.S. Justice Dept. Enter Settlement Over IEEPA Violations
Mar 26, 2015 08:34AM WaferGen Bio-systems Gains After Announcing Partnership with Procter & Gamble (WGBS) (PG)
Mar 26, 2015 08:32AM Aldeyra Therapeut (ALDX) Commences NS2 Phase 2 Enrollment
Mar 26, 2015 08:31AM Merck (MRK), American Diabetes Association Enter Collaboration
Mar 26, 2015 08:03AM ERBA Diagnostics (ERB) Unit to Sell Former Miami Facilities in $23M Deal
Mar 26, 2015 07:49AM Ceres (CERE) Advances Biotech Sugarcane Trials
Mar 26, 2015 07:36AM Gray Television (GTN) Prices 12M Common Offering at $13/Share
Mar 26, 2015 07:34AM Cardica (CRDC) Announces Restructuring
Mar 26, 2015 07:32AM SunEdison (SUNE) Enters 2.5-MW Module Supply Agreement with City of Long Beach
Mar 26, 2015 07:30AM Diplomat Pharmacy (DPLO) Prices Larger 8.54M Common Follow-on at $29/Share
Mar 26, 2015 07:23AM Rovi Corp. (ROVI) Issues Statement on Netflix (NFLX) Litigation
Mar 26, 2015 07:20AM Netlist (NLST) Updates on Verdict in Diablo Technologies Litigation; Will 'Vigorously' Pursue IP Suit
Mar 26, 2015 07:08AM pSivida (PSDV) Announces Completion of Medidur Phase 3 Enrollment
Mar 26, 2015 07:06AM Galena Biopharma (GALE) Announces Enrollment Expansion of NeuVax Combo Phase 2b
Mar 26, 2015 07:05AM Trina Solar (TSL) Supplies 6.9-MW of PV Modules to Anesco Solar Farm
Mar 26, 2015 07:04AM Conatus Pharmaceuticals (CNAT) Emricasan Phase 2 Met Primary Endpoint in NAFLD
Mar 26, 2015 06:33AM Pacira Pharma (PCRX) Reports Significant Data from EXPAREL in Reducing Pain of Knee, Hip Replacement Patients
Mar 26, 2015 06:27AM Citizens Financial Group (CFG) Prices 135M Common Secondary Offering at $23.75/Share
View Older Stories